Correction of the increase in embryonic HK2 protein in high-glucose-concentration cultures by 5–20 μM tRES + HESP suggests that Glo1 inducer treatment may prevent glycolytic overload in the embryo of a mother with diabetes and thus produce a therapeutic response in diabetic embryopathy. This evidence concerns the gene HK2 and diabetes mellitus.